We are committed to developing novel classes of microbiome diagnostics and therapeutics that will accelerate Hong Kong into a world-class microbiome biotechnology hub.

 

WHO ARE WE?

Just as Magic is science yet to be discovered, the Microbiota I-Center (MagIC) harnesses and translates the human microbiome into cutting-edge innovations for early disease detection and prevention.

 

MagIC focuses on advancing science in the gut microbiome and promoting entrepreneurship. It is committed to developing a novel class of microbiome diagnostics and live biotherapeutics for common diseases including obesity, cancer, autism, inflammatory disorders and COVID-19, that will not only transform lives of patients and their families, but also accelerate Hong Kong into a world-class microbiome biotechnology hub. 

Our body has 2 sets of genomes: human and gut microbial genomes. We have 30 trillion human cells, but 39 trillion microbial cells. We have 20,000 human genes, which is only 1% of us. We are more microbes than human!

We cannot edit our human genome to produce superhumans, but we can manipulate our gut microbiome to modify our risk profile, improve treatment outcomes, and even cure diseases. “Microbiome Medicine” offers hope of telling what you are, what you may become and most importantly, change your fate.

what is microbiome medicine
 

WHAT IS MICROBIOME MEDICINE?

Leaders in business, science and strategy who are using their expertise to support our vision to Create Magics.

DIRECTORS

Prof Siew Ng
Prof Siew Ng

Director

Prof Francis Chan
Prof Francis Chan

Director

RESEARCH & DEVELOPMENT

Thomas Ling
Thomas Ling

Director Operation of Stool Bank

Lin Zhang
Lin Zhang

Project Leader

Jielun Hu
Jielun Hu

Senior Scientist

Jessie Liang
Jessie Liang

Project Leader

Wendy Zhang
Wendy Zhang

Project Leader

Gabriel Lee
Gabriel Lee

Scientific Officer

CP Cheung
CP Cheung

Lab Manager

Lulu Xu
Lulu Xu

Project Leader

Qin Liu
Qin Liu

Project Leader

OPERATION

CLINICAL

 

TEAM

 

COLLABORATORS

We believe that collaboration is key to unlocking the full potential of the microbiome. As such, we have partnerships with leading clinician researchers and institutions driving human microbiome research around the globe—from the United States to Australia and United Kingdom.

logo of University of Cambridge
Dr Nicole Kaneider

Dr Nicole Kaneider

Prof Arthur Kaser

Prof Arthur Kaser

Prof David T. Rubin
Prof Eugene B. Chang
Logo The University of Melbourne
Prof Michael Kamm

Prof Michael Kamm

Logo University of Chicago

Prof David T. Rubin

Prof Eugene B. Chang